Cargando…
Endometrial Cancer: What Is New in Adjuvant and Molecularly Targeted Therapy?
Endometrial cancer is the most common gynaecological cancer in western countries. Radiotherapy remains the mainstay of postoperative management, but accumulating data show that adjuvant chemotherapy may display promising results after staging surgery. The prognosis of patients with metastatic diseas...
Autores principales: | Zagouri, Flora, Bozas, George, Kafantari, Eftichia, Tsiatas, Marinos, Nikitas, Nikitas, Dimopoulos, Meletios-A., Papadimitriou, Christos A. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2817540/ https://www.ncbi.nlm.nih.gov/pubmed/20148071 http://dx.doi.org/10.1155/2010/749579 |
Ejemplares similares
-
Treatment of early uterine sarcomas: disentangling adjuvant modalities
por: Zagouri, Flora, et al.
Publicado: (2009) -
Evaluation of the prognostic value of CD3, CD8, and FOXP3 mRNA expression in early‐stage breast cancer patients treated with anthracycline‐based adjuvant chemotherapy
por: Tsiatas, Marinos, et al.
Publicado: (2018) -
Impact of CDK4/6 Inhibitors on Aromatase Inhibitor-Associated Musculoskeletal Syndrome (AIMSS) in the Adjuvant Setting
por: Skafida, Efthymia, et al.
Publicado: (2023) -
Olaratumab administered in two cases of phyllodes tumour of the breast: end of the beginning?
por: Kyriazoglou, Anastasios, et al.
Publicado: (2019) -
Gestational trophoblastic neoplasia with retroperitoneal metastases: A fatal complication
por: Thomakos, Nikolaos, et al.
Publicado: (2010)